معرفی
Dr. Ulrich Hintermair is a Reader (equivalent to Associate Professor) and Royal Society University Research Fellow in the Department of Chemistry at the University of Bath, UK. He leads a research group focused on developing catalytic methodologies for sustainable chemistry and clean energy, with particular expertise in organometallics, homogeneous catalysis, and operando spectroscopy. He is affiliated with the Centre for Sustainable Chemical Technologies (CSCT) and the Institute of Sustainability and Climate Change.
His research spans multiple areas of sustainable chemistry:
- Polymetallic base metal complexes for cooperative catalysis
- Electrocatalysis for renewable energy conversion
- Operando spectroscopy (FlowNMR) for mechanism-guided homogeneous catalyst development
- Process and phase engineering with near- and supercritical fluids for continuous-flow catalysis
Dr. Hintermair's recent publications demonstrate expertise in homogeneous catalysis, organometallic synthesis, and sustainable chemistry applications. His work frequently employs FlowNMR spectroscopy for real-time reaction monitoring, with applications ranging from biomass conversion to vitamin synthesis and polymer production. The research significantly contributes to multiple United Nations Sustainable Development Goals related to sustainable chemistry and clean energy.
His notable recognition includes the prestigious Royal Society University Research Fellowship, supporting his innovative work in sustainable chemistry. Additional projects include 'Fast and Quantitative Heteronuclear FlowNMR Spectroscopy Techniques for Real-time Reaction Monitoring' and 'Advanced Kinetic Analyses of Complex Catalytic Reaction Mechanisms via Automated, Simultaneous Multi-technique Spectroscopy'.
Dr. Hintermair actively supervises PhD students in his research group, with recent graduates including Adam Khan (who worked on reductive amination with Syngenta) and Owen Harper. He frequently advertises PhD positions, often in collaboration with industry partners like AstraZeneca and Syngenta. He is also instrumental in the Dynamic Reaction Monitoring (DReaM) Facility at the University of Bath, which provides advanced capabilities for real-time reaction monitoring and hosts an annual Reaction Monitoring Symposium.
